Zhitong Finance App learned that on August 21, Hang Seng Index Company announced the results of the Hang Seng Index series quarterly review results up to June 30, 2026. Among them, Libang Pharmaceutical-B (09637.HK) was included in the Hang Seng Composite Index. The index changes will be implemented after the market closes on September 4 (Friday) and will take effect on September 7 (Monday). At that time, the Shanghai and Shenzhen Stock Exchange will adjust the scope of investment targets of Hong Kong Stock Connect accordingly.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.